Results 1 to 10 of about 70,621 (279)

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

open access: green, 2022
Keitaro Shimozaki   +12 more
openalex   +2 more sources

373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study [PDF]

open access: bronze
Norikazu Masuda   +19 more
openalex   +1 more source

DESENSITIZATION TO PERTUZUMAB/TRASTUZUMAB/HYALURONIDASE-ZZXF IN A PATIENT WITH HYMENOPTERA ANAPHYLAXIS [PDF]

open access: bronze
V. Saldana-Fraire   +4 more
openalex   +1 more source

Life-Saving Reduced Dose of Trastuzumab-Deruxtecan in Metastatic HER2-Low Metastatic Breast Cancer with Major Hepatic Insufficiency: A Case Report [PDF]

open access: diamond
Nahed Damaj   +12 more
openalex   +1 more source

Socioeconomic disparities in long-term heart failure risk of trastuzumab with or without anthracyclines in early-stage breast cancer: a SEER-Medicare database analysis [PDF]

open access: gold
Karissa Britten   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy